Children may be more likely to survive a rare, potentially fatal influenza complication if they receive rapid treatment for ...

For decades, medical professionals debated whether a common antiviral medication used to treat flu in children caused ...

Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens.

Neutralising monoclonal antibodies (NAbs) are being developed for future respiratory virus threats, notably highly pathogenic ...

Influenza-associated acute necrotizing encephalopathy in children is associated with high morbidity and mortality.

The global infectious disease treatment market is projected to grow from $72.5 billion in 2025 to $101 billion by 2030, with ...

By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — A life-threatening condition involving ...

Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex. This is the first FDA-cleared assay utilizing Roche's innovative TAGS (Temperature ...

A Stanford-led study found that children facing a rare, deadly flu complication involving brain swelling and runaway immune ...